One of the problems facing the majority of patients that qualify for a medical cannabis recommendation is that many of them have debilitating conditions that often hinder or limit mobility and preclude them from driving—which makes it very difficult to get in to see a physician.
To this end, www.myfloridagreen.com
was created to remove the hurdles that these patients face. A virtual online clinic platform designed by industry experts and medical leaders, the app handles patient aggregation, vetting and qualification, and the establishment of a doctor/patient relationship.
“Through the use of telemedicine and virtual technology, a patient can even have an actual face-to-face consultation with a medical provider while remaining in the comfort of his or her own home,” explained myfloridagreen.com creator Nick Garulay.
The HIPAA-compliant platform streamlines patient flow for physicians and more importantly, assists sick patients with debilitative and terminal illnesses. Already, www. myfloridagreen.com has more than 3,500 patients registered with the application since the passing of Amendment 2, the Florida Medical Marijuana Legalization Initiative, on November 8.
As laws get implemented and doctors and patients start to navigate this emerging process, there are going to be large volumes of data that need to be inputted, archived, queried and protected, and Garulay and his team are already in the process of creating software to handle the patient data currently required by the state registry, the College of Pharmacy registry, and the medical cannabis card registration that was recently added to the regulations.
“These legislatively mandated reportable data sets, combined with the existing functionality of the current platform, will allow the medical cannabis recommendation process to be applied for, monitored, regulated, tracked, and enforced on one solid system,” he explained.
Despite the fact that this could provide a streamlined way for patients and doctors to communicate, a proposed ban on telemedicine being used to prescribe medical cannabis by caregivers in the state of Florida could derail the process.
“If passed, the ban would have a detrimental and negative impact on many non-ambulatory patients that could not obtain a recommendation via a traditional office visit,” explained Garulay, adding that the legislative language in the ban echoes the current telemedicine law that prohibits a controlled substance to be prescribed through telemedicine unless it is done by a psychiatrist.
“It is my ultimate goal to create a virtual process that facilitates and adheres to all of the legal requirements—from the initial consultation to the final dispensing of the medication for the qualifying patients in need,” he added. “By partnering with the state, together we can manage this immense undertaking in a way that meets the statutory requirements, as well as creates a unique way to help patients when a traditional office visit is not an option.”